{"date":"2025-11-14","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2025-11-14-2030-532esv","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-11-14","time":"20:30:43","subject":"代子公司Lotus International Pte. Ltd.公告資金貸與案","clause":"第23款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-11-14 20:30，「代子公司Lotus International Pte. Ltd.公告資金貸與案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-11-14-2030-17536xd","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-11-14","time":"20:30:24","subject":"本公司及子公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第一款規定公告","clause":"第23款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-11-14 20:30，「本公司及子公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第一款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-11-14-1814-1ozpch2","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"18:14:48","subject":"代子公司玉晟管理顧問(股)公司公告處分有價證券達公告標準","clause":"第20款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-11-14 18:14，「代子公司玉晟管理顧問(股)公司公告處分有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-11-14-1753-1ye5yun","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-11-14","time":"17:53:44","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-11-14 17:53，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-11-14-1718-wl9qsf","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"17:18:15","subject":"公告本公司董事會通過114年第三季財務報告","clause":"第43款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-11-14 17:18，「公告本公司董事會通過114年第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-11-14-1650-1ws4fhw","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-11-14","time":"16:50:35","subject":"本公司受邀參加華南永昌證券2025年冬季產業趨勢暨企業論壇","clause":"第12款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-11-14 16:50，「本公司受邀參加華南永昌證券2025年冬季產業趨勢暨企業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-11-14-1650-ps6yjb","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-11-14","time":"16:50:18","subject":"本公司受邀參加櫃買中心與麥格理證券舉辦之「Macquarie Taiwan Conference」","clause":"第12款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-11-14 16:50，「本公司受邀參加櫃買中心與麥格理證券舉辦之「Macquarie Taiwan Conference」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-11-14-1636-4fh1lv","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"16:36:36","subject":"公告本公司更換股務代理機構業經集保公司函覆准予備查","clause":"第53款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-11-14 16:36，「公告本公司更換股務代理機構業經集保公司函覆准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-11-14-1524-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"15:24:13","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-11-14 15:24，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-11-14-1523-svdi6j","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"15:23:10","subject":"本公司董事會決議股利分派及資本公積發放現金","clause":"第14款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-11-14 15:23，「本公司董事會決議股利分派及資本公積發放現金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-11-14-1522-sp1z2g","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"15:22:10","subject":"公告本公司董事會通過114年第3季合併財務報表","clause":"第31款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-11-14 15:22，「公告本公司董事會通過114年第3季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-11-14-1514-ke1qih","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-11-14","time":"15:14:54","subject":"公告本公司更換主辦輔導推薦證券商事宜","clause":"第44款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-11-14 15:14，「公告本公司更換主辦輔導推薦證券商事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-11-14-1514-wnp3jb","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"15:14:33","subject":"公告本公司受邀參加永豐金證券舉辦之法說會議","clause":"第12款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-11-14 15:14，「公告本公司受邀參加永豐金證券舉辦之法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-11-14-1433-dehtrl","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"14:33:09","subject":"本公司受邀參加元富證券舉辦之法人說明會，說明公司產品及技術平台研發現況及未來發展策略","clause":"第12款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-11-14 14:33，「本公司受邀參加元富證券舉辦之法人說明會，說明公司產品及技術平台研發現況及未來發展策略」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2025-11-14-1412-1kvcr9w","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2025-11-14","time":"14:12:12","subject":"公告本公司受邀參加台新證券舉辦之興櫃前法人說明會","clause":"第9款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2025-11-14 14:12，「公告本公司受邀參加台新證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2025-11-14-1402-zjkb28","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2025-11-14","time":"14:02:02","subject":"公告本公司自114年11月24日登錄興櫃買賣","clause":"第9款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2025-11-14 14:02，「公告本公司自114年11月24日登錄興櫃買賣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-11-14-1049-u63tzq","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-11-14","time":"10:49:34","subject":"公告本公司取得衍生性商品","clause":"第20款","fact_date":"2025-11-14","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-11-14 10:49，「公告本公司取得衍生性商品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}